Drug
SD 101 6 0
SD 101 6 0: highest development phase Phase 3, developed by Amicus Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Amicus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| SD-101-6.0 cream NCT02670330 | Phase 3 | Epidermolysis Bullosa |
| SD-101-6.0 cream NCT02384460 | Phase 3 | Epidermolysis Bullosa |
Latest
No recent events.
Follow SD 101 6 0 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.